deltatrials
Recruiting NA INTERVENTIONAL 1-arm NCT07115914

PSMA PET for Surveillance After Focal Therapy

Prospective Evaluation of PSMA PET Imaging in Surveillance Post-Focal Therapy for Prostate Cancer (PSMA-FT Surveillance Study)

Sponsor: Blue Earth Diagnositcs

Conditions Prostate Cancer (Adenocarcinoma) Prostate Cancer (Diagnosis) Prostate Cancer Metastatic Disease
Interventions PSMA PET/CT scan
Updated 2 times since 2025 Last updated: Feb 13, 2026 Started: Nov 19, 2025 Primary completion: Aug 1, 2028 Completion: Aug 1, 2028
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Prostate Cancer (Adenocarcinoma) and Prostate Cancer (Diagnosis), this trial is actively recruiting participants. The trial is conducted by Blue Earth Diagnositcs and has accumulated 2 data snapshots since 2025. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Sep 2025 – ~Feb 2026 · 5 months · monthly snapshotNot Yet Recruiting~Feb 2026 – present · 5 months · monthly snapshotRecruiting

Change History

2 versions recorded

  1. Feb 2026 — Present [monthly]

    Recruiting NA

    Status: Not Yet Recruiting → Recruiting

  2. Sep 2025 — Feb 2026 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Blue Earth Diagnositcs
  • University of Chicago
Data source: University of Chicago

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations